The brains behind the BAD

Article

Drs Belin and Ambrosio's Enhanced Ectasia module is a keratoconus index, based on pachy

The early detection of ectatic change is of paramount importance to the refractive surgeon. Anterior curvature and ultrasonic pachymetry, alone, does not provide enough information to detect early corneal disease. The combination of anterior and posterior elevation and complete pachymetric data gives the clinician a more complete view of the structure of the cornea and allows for more effective screening. The OCULUS Pentacam's Scheimpflug Cross-sectional imaging (OCULUS Optikgerate GmbH, Wetzlar, Germany) provides for a three-dimensional reconstruction of the anterior segment, making possible the assessment of the anterior and posterior corneal surfaces and the creation of a complete pachymetric map. The Belin / Ambrósio Enhanced Ectasia Display (BAD display) was designed to utilise the data supplied by the Pentacam's rotating Scheimpflug camera and provide a comprehensive keratoconus screening display. The display combines the anterior and posterior elevation and pachymetric data into one all-inclusive display giving the clinician a more complete overview of the corneal shape and allowing for quick and effective screening of refractive surgery patients.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.